These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 18633430

  • 21. Arsenic trioxide circumvents multidrug resistance based on different mechanisms in human leukemia cell lines.
    Seo T, Urasaki Y, Takemura H, Ueda T.
    Anticancer Res; 2005; 25(2A):991-8. PubMed ID: 15868938
    [Abstract] [Full Text] [Related]

  • 22. Role of the p38 mitogen-activated protein kinase pathway in the generation of arsenic trioxide-dependent cellular responses.
    Giafis N, Katsoulidis E, Sassano A, Tallman MS, Higgins LS, Nebreda AR, Davis RJ, Platanias LC.
    Cancer Res; 2006 Jul 01; 66(13):6763-71. PubMed ID: 16818652
    [Abstract] [Full Text] [Related]

  • 23. The novel arsenical darinaparsin is transported by cystine importing systems.
    Garnier N, Redstone GG, Dahabieh MS, Nichol JN, del Rincon SV, Gu Y, Bohle DS, Sun Y, Conklin DS, Mann KK, Miller WH.
    Mol Pharmacol; 2014 Apr 01; 85(4):576-85. PubMed ID: 24431147
    [Abstract] [Full Text] [Related]

  • 24. Antimony-trioxide- and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cell lines, recruitment of caspases, and loss of mitochondrial membrane potential are enhanced by modulators of the cellular glutathione redox system.
    Lösler S, Schlief S, Kneifel C, Thiel E, Schrezenmeier H, Rojewski MT.
    Ann Hematol; 2009 Nov 01; 88(11):1047-58. PubMed ID: 19301004
    [Abstract] [Full Text] [Related]

  • 25. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.
    Yan H, Peng ZG, Wu YL, Jiang Y, Yu Y, Huang Y, Zhu YS, Zhao Q, Chen GQ.
    Haematologica; 2005 Dec 01; 90(12):1607-16. PubMed ID: 16330433
    [Abstract] [Full Text] [Related]

  • 26. The overexpression of multidrug resistance-associated proteins and gankyrin contribute to arsenic trioxide resistance in liver and gastric cancer cells.
    Chen X, Zhang M, Liu LX.
    Oncol Rep; 2009 Jul 01; 22(1):73-80. PubMed ID: 19513507
    [Abstract] [Full Text] [Related]

  • 27. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.
    Rego EM, He LZ, Warrell RP, Wang ZG, Pandolfi PP.
    Proc Natl Acad Sci U S A; 2000 Aug 29; 97(18):10173-8. PubMed ID: 10954752
    [Abstract] [Full Text] [Related]

  • 28. The novel arsenical Darinaparsin circumvents BRG1-dependent, HO-1-mediated cytoprotection in leukemic cells.
    Garnier N, Petruccelli LA, Molina MF, Kourelis M, Kwan S, Diaz Z, Schipper HM, Gupta A, del Rincon SV, Mann KK, Miller WH.
    Leukemia; 2013 Nov 29; 27(11):2220-8. PubMed ID: 23426167
    [Abstract] [Full Text] [Related]

  • 29. Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells.
    Guo W, Wang H, Zhao W, Zhu J, Ju B, Wang X.
    Chin Med J (Engl); 2001 Jan 29; 114(1):30-4. PubMed ID: 11779431
    [Abstract] [Full Text] [Related]

  • 30. Arsenic trioxide inhibits nuclear receptor function via SEK1/JNK-mediated RXRalpha phosphorylation.
    Mann KK, Padovani AM, Guo Q, Colosimo AL, Lee HY, Kurie JM, Miller WH.
    J Clin Invest; 2005 Oct 29; 115(10):2924-33. PubMed ID: 16184197
    [Abstract] [Full Text] [Related]

  • 31. MER1, a novel organic arsenic derivative, has potent PML-RARalpha-independent cytotoxic activity against leukemia cells.
    Golemovic M, Quintás-Cardama A, Manshouri T, Orsolic N, Duzkale H, Johansen M, Freireich EJ, Kantarjian H, Zingaro RA, Verstovsek S.
    Invest New Drugs; 2010 Aug 29; 28(4):402-12. PubMed ID: 19468689
    [Abstract] [Full Text] [Related]

  • 32. Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells.
    Yang CH, Kuo ML, Chen JC, Chen YC.
    Br J Cancer; 1999 Nov 29; 81(5):796-9. PubMed ID: 10555748
    [Abstract] [Full Text] [Related]

  • 33. Resistance of human multidrug resistance-associated protein 1-overexpressing lung tumor cells to the anticancer drug arsenic trioxide.
    Vernhet L, Allain N, Payen L, Anger JP, Guillouzo A, Fardel O.
    Biochem Pharmacol; 2001 Jun 01; 61(11):1387-91. PubMed ID: 11331074
    [Abstract] [Full Text] [Related]

  • 34. Sensitivity of leukemic T-cell lines to arsenic trioxide cytotoxicity is dependent on the induction of phosphatase B220/CD45R expression at the cell surface.
    Benbijja M, Mellouk A, Bobé P.
    Mol Cancer; 2014 Nov 19; 13():251. PubMed ID: 25410152
    [Abstract] [Full Text] [Related]

  • 35. Arsenic trioxide-induced apoptosis of Hep-2 cell line through modulating intracellular glutathione (GSH) level.
    Cheng B, Yang X, An L, Gao B, Liu X.
    Auris Nasus Larynx; 2010 Feb 19; 37(1):89-94. PubMed ID: 19574005
    [Abstract] [Full Text] [Related]

  • 36. [Potentiation of arsenic trioxide-induced apoptosis by retinoic acid in retinoic acid sensitive and resistant HL-60 myeloid leukemia cells].
    Huang X.
    Chin Med J (Engl); 2000 Jun 19; 113(6):498-501. PubMed ID: 11775865
    [Abstract] [Full Text] [Related]

  • 37. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
    Marasca R, Zucchini P, Galimberti S, Leonardi G, Vaccari P, Donelli A, Luppi M, Petrini M, Torelli G.
    Haematologica; 1999 Nov 19; 84(11):963-8. PubMed ID: 10553155
    [Abstract] [Full Text] [Related]

  • 38. [Basic and clinical studies of the gene product-targeting therapy based on leukemogenesis--editorial].
    Chen SJ, Chen LJ, Zhou GB.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb 19; 13(1):1-8. PubMed ID: 15748426
    [Abstract] [Full Text] [Related]

  • 39. Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro.
    Ora I, Bondesson L, Jönsson C, Ljungberg J, Pörn-Ares I, Garwicz S, Pâhlman S.
    Biochem Biophys Res Commun; 2000 Oct 14; 277(1):179-85. PubMed ID: 11027660
    [Abstract] [Full Text] [Related]

  • 40. Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients.
    Rousselot P, Labaume S, Marolleau JP, Larghero J, Noguera MH, Brouet JC, Fermand JP.
    Cancer Res; 1999 Mar 01; 59(5):1041-8. PubMed ID: 10070961
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.